Angiotensin Ii Receptor Blockers (Arbs), Combinations

1 trials CCardiology

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

13 Countries

Phase III/IV

Phase III/IV: 1

Indications tested

IgA nephropathy 1

Sponsors using this IMP

Novartis Pharma AG 1

All trials

1 total

A rollover extension program (REP) to evaluate the long-term safety and tolerability of open label iptacopan in adult participants with prim… Ended

2023-508690-92-00 Phase III/IV 13 countries Novartis Pharma AG

Showing 1–1 of 1 trials

← All drugs A–Z